Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Drug Repurposing market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Drug Repurposing market. Detailed analysis of key players, along with key growth strategies adopted by Drug Repurposing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Biovista
Novartis
Allergan
Astellas Pharma
NuMedii
Pfizer
AbbVie
By Type:
Oncology
CNS Diseases
Neurodegenerative Diseases
Others
By End-User:
Hospitals
Ambulatory Surgical Centers
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Drug Repurposing Market
-
1.3 Market Segment by Type
-
1.3.1 China Drug Repurposing Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.3.2 China Drug Repurposing Market Size and Growth Rate of CNS Diseases from 2016 to 2027
-
1.3.3 China Drug Repurposing Market Size and Growth Rate of Neurodegenerative Diseases from 2016 to 2027
-
1.3.4 China Drug Repurposing Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Drug Repurposing Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Drug Repurposing Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
1.4.3 China Drug Repurposing Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Drug Repurposing Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Drug Repurposing by Major Types
-
3.4.1 Market Size and Growth Rate of Oncology
-
3.4.2 Market Size and Growth Rate of CNS Diseases
-
3.4.3 Market Size and Growth Rate of Neurodegenerative Diseases
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Drug Repurposing Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Drug Repurposing by Major End-Users
-
4.4.1 Market Size and Growth Rate of Drug Repurposing in Hospitals
-
4.4.2 Market Size and Growth Rate of Drug Repurposing in Ambulatory Surgical Centers
-
4.4.3 Market Size and Growth Rate of Drug Repurposing in Others
5 Market Analysis by Regions
-
5.1 China Drug Repurposing Production Analysis by Regions
-
5.2 China Drug Repurposing Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Drug Repurposing Landscape Analysis
-
6.1 North China Drug Repurposing Landscape Analysis by Major Types
-
6.2 North China Drug Repurposing Landscape Analysis by Major End-Users
7 Central China Drug Repurposing Landscape Analysis
-
7.1 Central China Drug Repurposing Landscape Analysis by Major Types
-
7.2 Central China Drug Repurposing Landscape Analysis by Major End-Users
8 South China Drug Repurposing Landscape Analysis
-
8.1 South China Drug Repurposing Landscape Analysis by Major Types
-
8.2 South China Drug Repurposing Landscape Analysis by Major End-Users
9 East China Drug Repurposing Landscape Analysis
-
9.1 East China Drug Repurposing Landscape Analysis by Major Types
-
9.2 East China Drug Repurposing Landscape Analysis by Major End-Users
10 Northeast China Drug Repurposing Landscape Analysis
-
10.1 Northeast China Drug Repurposing Landscape Analysis by Major Types
-
10.2 Northeast China Drug Repurposing Landscape Analysis by Major End-Users
11 Southwest China Drug Repurposing Landscape Analysis
-
11.1 Southwest China Drug Repurposing Landscape Analysis by Major Types
-
11.2 Southwest China Drug Repurposing Landscape Analysis by Major End-Users
12 Northwest China Drug Repurposing Landscape Analysis
-
12.1 Northwest China Drug Repurposing Landscape Analysis by Major Types
-
12.2 Northwest China Drug Repurposing Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Biovista
-
13.1.1 Biovista Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Novartis
-
13.2.1 Novartis Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Allergan
-
13.3.1 Allergan Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Astellas Pharma
-
13.4.1 Astellas Pharma Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 NuMedii
-
13.5.1 NuMedii Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Pfizer
-
13.6.1 Pfizer Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 AbbVie
-
13.7.1 AbbVie Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Drug Repurposing Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure China Drug Repurposing Market Size and Growth Rate of CNS Diseases from 2016 to 2027
-
Figure China Drug Repurposing Market Size and Growth Rate of Neurodegenerative Diseases from 2016 to 2027
-
Figure China Drug Repurposing Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Drug Repurposing Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Drug Repurposing Market Size and Growth Rate of Ambulatory Surgical Centers from 2016 to 2027
-
Figure China Drug Repurposing Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Drug Repurposing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Drug Repurposing Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Drug Repurposing
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Drug Repurposing by Different Types from 2016 to 2027
-
Table Consumption Share of Drug Repurposing by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of CNS Diseases
-
Figure Market Size and Growth Rate of Neurodegenerative Diseases
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Drug Repurposing by Different End-Users from 2016 to 2027
-
Table Consumption Share of Drug Repurposing by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Ambulatory Surgical Centers
-
Figure Market Size and Growth Rate of Others
-
Table China Drug Repurposing Production by Regions
-
Table China Drug Repurposing Production Share by Regions
-
Figure China Drug Repurposing Production Share by Regions in 2016
-
Figure China Drug Repurposing Production Share by Regions in 2021
-
Figure China Drug Repurposing Production Share by Regions in 2027
-
Table China Drug Repurposing Consumption by Regions
-
Table China Drug Repurposing Consumption Share by Regions
-
Figure China Drug Repurposing Consumption Share by Regions in 2016
-
Figure China Drug Repurposing Consumption Share by Regions in 2021
-
Figure China Drug Repurposing Consumption Share by Regions in 2027
-
Table North China Drug Repurposing Consumption by Types from 2016 to 2027
-
Table North China Drug Repurposing Consumption Share by Types from 2016 to 2027
-
Figure North China Drug Repurposing Consumption Share by Types in 2016
-
Figure North China Drug Repurposing Consumption Share by Types in 2021
-
Figure North China Drug Repurposing Consumption Share by Types in 2027
-
Table North China Drug Repurposing Consumption by End-Users from 2016 to 2027
-
Table North China Drug Repurposing Consumption Share by End-Users from 2016 to 2027
-
Figure North China Drug Repurposing Consumption Share by End-Users in 2016
-
Figure North China Drug Repurposing Consumption Share by End-Users in 2021
-
Figure North China Drug Repurposing Consumption Share by End-Users in 2027
-
Table Central China Drug Repurposing Consumption by Types from 2016 to 2027
-
Table Central China Drug Repurposing Consumption Share by Types from 2016 to 2027
-
Figure Central China Drug Repurposing Consumption Share by Types in 2016
-
Figure Central China Drug Repurposing Consumption Share by Types in 2021
-
Figure Central China Drug Repurposing Consumption Share by Types in 2027
-
Table Central China Drug Repurposing Consumption by End-Users from 2016 to 2027
-
Table Central China Drug Repurposing Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Drug Repurposing Consumption Share by End-Users in 2016
-
Figure Central China Drug Repurposing Consumption Share by End-Users in 2021
-
Figure Central China Drug Repurposing Consumption Share by End-Users in 2027
-
Table South China Drug Repurposing Consumption by Types from 2016 to 2027
-
Table South China Drug Repurposing Consumption Share by Types from 2016 to 2027
-
Figure South China Drug Repurposing Consumption Share by Types in 2016
-
Figure South China Drug Repurposing Consumption Share by Types in 2021
-
Figure South China Drug Repurposing Consumption Share by Types in 2027
-
Table South China Drug Repurposing Consumption by End-Users from 2016 to 2027
-
Table South China Drug Repurposing Consumption Share by End-Users from 2016 to 2027
-
Figure South China Drug Repurposing Consumption Share by End-Users in 2016
-
Figure South China Drug Repurposing Consumption Share by End-Users in 2021
-
Figure South China Drug Repurposing Consumption Share by End-Users in 2027
-
Table East China Drug Repurposing Consumption by Types from 2016 to 2027
-
Table East China Drug Repurposing Consumption Share by Types from 2016 to 2027
-
Figure East China Drug Repurposing Consumption Share by Types in 2016
-
Figure East China Drug Repurposing Consumption Share by Types in 2021
-
Figure East China Drug Repurposing Consumption Share by Types in 2027
-
Table East China Drug Repurposing Consumption by End-Users from 2016 to 2027
-
Table East China Drug Repurposing Consumption Share by End-Users from 2016 to 2027
-
Figure East China Drug Repurposing Consumption Share by End-Users in 2016
-
Figure East China Drug Repurposing Consumption Share by End-Users in 2021
-
Figure East China Drug Repurposing Consumption Share by End-Users in 2027
-
Table Northeast China Drug Repurposing Consumption by Types from 2016 to 2027
-
Table Northeast China Drug Repurposing Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Drug Repurposing Consumption Share by Types in 2016
-
Figure Northeast China Drug Repurposing Consumption Share by Types in 2021
-
Figure Northeast China Drug Repurposing Consumption Share by Types in 2027
-
Table Northeast China Drug Repurposing Consumption by End-Users from 2016 to 2027
-
Table Northeast China Drug Repurposing Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Drug Repurposing Consumption Share by End-Users in 2016
-
Figure Northeast China Drug Repurposing Consumption Share by End-Users in 2021
-
Figure Northeast China Drug Repurposing Consumption Share by End-Users in 2027
-
Table Southwest China Drug Repurposing Consumption by Types from 2016 to 2027
-
Table Southwest China Drug Repurposing Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Drug Repurposing Consumption Share by Types in 2016
-
Figure Southwest China Drug Repurposing Consumption Share by Types in 2021
-
Figure Southwest China Drug Repurposing Consumption Share by Types in 2027
-
Table Southwest China Drug Repurposing Consumption by End-Users from 2016 to 2027
-
Table Southwest China Drug Repurposing Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Drug Repurposing Consumption Share by End-Users in 2016
-
Figure Southwest China Drug Repurposing Consumption Share by End-Users in 2021
-
Figure Southwest China Drug Repurposing Consumption Share by End-Users in 2027
-
Table Northwest China Drug Repurposing Consumption by Types from 2016 to 2027
-
Table Northwest China Drug Repurposing Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Drug Repurposing Consumption Share by Types in 2016
-
Figure Northwest China Drug Repurposing Consumption Share by Types in 2021
-
Figure Northwest China Drug Repurposing Consumption Share by Types in 2027
-
Table Northwest China Drug Repurposing Consumption by End-Users from 2016 to 2027
-
Table Northwest China Drug Repurposing Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Drug Repurposing Consumption Share by End-Users in 2016
-
Figure Northwest China Drug Repurposing Consumption Share by End-Users in 2021
-
Figure Northwest China Drug Repurposing Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Biovista
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biovista
-
Figure Sales and Growth Rate Analysis of Biovista
-
Figure Revenue and Market Share Analysis of Biovista
-
Table Product and Service Introduction of Biovista
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of NuMedii
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NuMedii
-
Figure Sales and Growth Rate Analysis of NuMedii
-
Figure Revenue and Market Share Analysis of NuMedii
-
Table Product and Service Introduction of NuMedii
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
